Human sTRAIL Receptor-1 (DR4)
產(chǎn)品名稱: Human sTRAIL Receptor-1 (DR4)
產(chǎn)品型號(hào): C02-310-18-100ug
產(chǎn)品展商: peprotech
產(chǎn)品文檔: 無相關(guān)文檔
簡(jiǎn)單介紹
上海創(chuàng)賽科學(xué)儀器有限公司提供上等C02-310-18-100ug;Human sTRAIL Receptor-1 (DR4);100ug，大量現(xiàn)貨火爆促銷中，歡迎來電洽談選購，更多產(chǎn)品請(qǐng)登錄www.ahbcpqn.cn
Human sTRAIL Receptor-1 (DR4)
的詳細(xì)介紹
產(chǎn)品名稱：Human sTRAIL Receptor-1 (DR4)
產(chǎn)品規(guī)格：
| C02-310-18-100ug | Human sTRAIL Receptor-1 (DR4) | 100ug | ￥4,900 |
| C02-310-18-10ug | Human sTRAIL Receptor-1 (DR4) | 10ug | ￥680 |
| C02-310-18-1mg | Human sTRAIL Receptor-1 (DR4) | 1mg | ￥21,000 |
| C02-310-18-500ug | Human sTRAIL Receptor-1 (DR4) | 500ug | ￥12,600 |
| C02-310-18-50ug | Human sTRAIL Receptor-1 (DR4) | 50ug | ￥1,960 |
關(guān) 鍵 字：Human sTRAIL Receptor-1 (DR4)
CANSPEC品質(zhì)提供的Human sTRAIL Receptor-1 (DR4)性能**，產(chǎn)品Human sTRAIL Receptor-1 (DR4)以其優(yōu)良的品質(zhì)滿足您不同實(shí)驗(yàn)的多種需求。
歡迎來電洽談選購，更多產(chǎn)品請(qǐng)登錄www.ahbcpqn.cn
Synonyms : | soluble TRAIL Receptor-1, DR4, TNFRSF10A, Apo2 |
Description : | TRAIL Receptor-1/DR4 and TRAIL Receptor-2/DR5 belong to the TNFR superfamily of transmembrane proteins and contain a cytoplasmic "death domain, " which can activate the cell's apoptotic machinery. These receptors are activated by binding to either membrane anchored or soluble TRAIL/Apo2L. Recombinant human soluble TRAIL Receptor-1/DR4 is a 22.7 kDa protein (215 amino acid residues) consisting of the TNFR homologous, cysteine rich portion of the extracellular domain. |
Catalog #: | 310-18 |
Source : | E.coli |
Stability : | The lyophilized protein is stable for at least 2 years from date of receipt at -200C. Reconstituted sTRAILR1 is stable for at least 3 months when stored in working aliquots with a carrier protein at -200C. Avoid repeated freeze/thaw cycles. |
Purity : | Greater than 98% by SDS-PAGE gel and HPLC analyses. |
Endotoxin Level : | Endotoxin level is less than 0.1 ng per µg (1EU/µg). |
Biological Activity : | Determined by its inhibitory effect of IL-8 production in human PBMC by human sTRAIL/Apo2L. 95% inhibition (100 ng/ml of s TRAIL/Apo2L) was reached using a concentration of 100 ng/ml of sTRAIL Receptor-1. |
AA Sequence : | MSGTGAAAAT PSKVWGSSAG RIEPRGGGRG ALPTSMGQHG PSARARAGRA PGPRPAREAS PRLRVHKTFK FVVVGVLLQV VPSSAATIKL HDQSIGTQQW EHSPLGELCP PGSHRSERPG ACNRCTEGVG YTNASQQLFA CLPCTACKSD EEERSPCTTT RNTACQCKPG TFRNDNSAEM CRKCSTGCPR GMVKVKDCTP WSDIECVHKE SGNGHN |
PubMed Link : | TRAIL+AND+Receptor+AND+DR4 |
Country of Origin : | USA |
